PLX PROTALIX BIOTHERAPEUTICS INC

Ownership history in TWO SIGMA SECURITIES, LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which TWO SIGMA SECURITIES, LLC reported a position in PROTALIX BIOTHERAPEUTICS INC (PLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2015 Q1)
Avg. % of fund
0.0%
First filed
2015 Q1
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 39,811 -12,509 -23.9% 0.01% $72K $1.80
2024 Q2 REDUCED 52,320 -32,993 -38.7% 0.00% $61K $1.17
2024 Q1 ADDED 85,313 +40,839 +91.8% 0.00% $107K $1.26
2023 Q4 ADDED 44,474 +29,198 +191.1% 0.00% $79K $1.78
2023 Q2 REDUCED 15,276 -5,484 -26.4% 0.00% $31K $2.00
2023 Q1 REDUCED 20,760 -36,367 -63.7% 0.00% $44K $2.10
2017 Q4 ADDED 57,127 +9,494 +19.9% 0.00% $38K $6.60
2017 Q3 ADDED 47,633 +36,488 +327.4% 0.00% $28K $5.80
2015 Q1 INITIATED 11,145 0.02% $20K $17.80
% of Fund (quarterly)    PLX price (monthly, adj. close)
← Back to TWO SIGMA SECURITIES, LLC Holdings